Nov 22 (Reuters) - Britain's competition watchdog fined U.S. firm Viatris 1.5 million pounds ($1.88 million) on Friday for violating an order during its investigation into Theramex's acquisition of European rights to two of Viatris's women's healthcare product ranges.
The Competition and Markets Authority $(CMA)$ said Viatris breached regulations by failing to obtain its consent before altering key staff and by not reporting the breach.
($1 = 0.7978 pounds)
(Reporting by DhanushVignesh Babu in Bengaluru; Editing by Savio D'Souza)
((DhanushVignesh.Babu@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments